Monday 20 March 2023

New number one trust CEO revealed

New number one trust CEO revealed The overarching theme of HSJ’s 2023 ranking of the NHS’s leading provider trust chief executives is one of change. Twenty-four of the names in the top 50 are new when compared to the 2022 list, although some have appeared in the rankings during previous years.

We also have a new number one chief executive – Angela Hillery, the leader of Northamptonshire Healthcare Foundation Trust and Leicestershire Partnership Trust. Health Service Journal

Wellingborough NHS chefs hoping to dish up a win at world famous competition

Wellingborough NHS chefs hoping to dish up a win at world famous competition Two local NHS chefs are set to cook up a storm in a high-profile competition alongside culinary challengers from across Britain.

Kerrey and Natasha – who work for Northamptonshire Healthcare NHS Foundation Trust (NHFT) – have been invited to take part in this year’s NHS 4 Nations Chef Challenge, part of the International Salon Culinaire, which is due to take place on 20 March 2023 at ExCeL, London. Northamptonshire Telegraph

Health care funding: Three key questions

Health care funding: Three key questions This analysis from the REAL Centre explores the latest health care funding figures, including how much funding has been committed, how it compares to historical levels and how it stacks up against what is needed to meet current pressures facing health services. The Health Foundation

Number of autistic people in mental health hospitals: latest data

 Number of autistic people in mental health hospitals: latest data This is the most up-to-date record of how many autistic people and people with learning disabilities, both adults and children, are currently in inpatient units in England. It also shows how long they have been in these units for, when their care and treatment is checked and what kind of unit they are in. National Autistic Society

Sector leaders to drive progress on national Dame Barbara Windsor Mission to beat dementia

Sector leaders to drive progress on national Dame Barbara Windsor Mission to beat dementia The UK Government has named two leaders in dementia research to spearhead the ambitious national Mission to tackle dementia, which was launched in memory of the late Dame Barbara Windsor.

Hilary Evans is the Chief Executive of Alzheimer’s Research UK, the largest charitable funder of dementia research in Europe. Nadeem Sarwar is currently a senior leader at Eisai, one of the world’s leading pharmaceutical companies. Together, they will convene industry, the NHS, academia and families living with dementia, to tackle this devastating illness. Department of Health and Social Care

Temporary border measures to enhance Covid surveillance from China removed

Temporary border measures to enhance Covid surveillance from China removed Precautionary and temporary measures introduced in January to improve the UK’s ability to detect potential new variants of Covid from China are being removed. Department of Health and Social Care

Inside the secret talks to end nurse and ambulance strikes

Inside the secret talks to end nurse and ambulance strikes It was one of the most bitter disputes in the history of the NHS, with the Royal College of Nursing staging its most extensive strike action ever. But as a deal with ministers was reached in England this week, the BBC can now reveal details of the secret and unprecedented talks. BBC News

See also:

Weight-loss: Are injections the answer to tackling obesity?

Weight-loss: Are injections the answer to tackling obesity? You cannot escape the hype around weight-loss injections.

Social media is full of before-and-after pictures. They are the source of wild gossip about Hollywood stars, and now the UK's National Health Service is going to pay for them.

You can understand the appeal. Excess weight affects our health and leads to stigma - and the mantra of "diet and exercise" has simply failed for most people.

But should we be calling semaglutide, the drug in question, a "miracle" or "skinny jab" when some doctors think it is as controversial as treatments get? Does the hype match the reality? Or are we failing to tackle the causes of obesity and just consigning people to a lifetime of medication? BBC News

See also:

Watchdog fears healthcare tech merger could push up NHS costs

Watchdog fears healthcare tech merger could push up NHS costs The competition watchdog has warned that a proposed merger between two healthcare technology specialists would lead to higher costs and “worse outcomes for the NHS and ultimately patients and UK taxpayers”.

The Competition and Markets Authority (CMA) found the £1.2bn deal for the US firm UnitedHealth to buy British rival EMIS could reduce competition to develop and supply digital and data analytics products to the health service. The Guardian

See also:

Four in 10 NHS hospitals in England found to use outdated equipment in Lib Dem study

Four in 10 NHS hospitals in England found to use outdated equipment in Lib Dem study Four in 10 NHS hospitals in England are using outdated medical equipment including 37-year-old X-ray machines, according to research from the Lib Dems, who are calling for extra funding to replace outdated devices.

NHS hospitals are using hundreds of old X-ray machines, CT scanners and radiotherapy machines, with some dating back to the 1980s, according to research based on freedom of information requests to 69 hospital trusts. Of these, 41 said they had at least one X-ray machine that was more than 20 years old. The Guardian

See also:

Doubts grow over number of NHS doctors helped by pension giveaway

Doubts grow over number of NHS doctors helped by pension giveaway The number of hospital doctors that could be helped by Jeremy Hunt’s pensions giveaway has been cast into doubt, after new figures revealed that only 100 of them left the NHS last year due to voluntary early retirement.

Criticism has mounted about the measure announced in the budget, which would scrap the up to 55% tax levied on lifetime pension pots worth just over £1m and raise the annual allowance threshold from £40,000 to £60,000. The Guardian

NHS to offer 'world's most expensive' £1.8m-a-dose drug to cure baby spinal disease

NHS to offer 'world's most expensive' £1.8m-a-dose drug to cure baby spinal disease Babies born with a genetic disease that can lead to a life expectancy of just two years without intervention will now be cured on the NHS with a new £1.8million drug.

Around 56 infants are born with severe spinal muscular atrophy (SMA) in England every year, which causes muscle weakness and can lead to paralysis.

The National Institute for Health and Care Excellence (Nice), the NHS watchdog, has approved the use of onasemnogene abeparvovec, branded as Zolgensma, for babies born with the condition. The Daily Mail